Sonoma Pharmaceuticals (SNOA) Current Leases (2017 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Current Leases of $151000.0 for Q1 2026, up 160.34% year-over-year from $58000.0 in Q1 2025, and up 3.42% quarter-over-quarter from $146000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Current Leases (2017 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Current Leases history runs 10 years deep, the most recent figure standing at $151000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 160.34% year-over-year to $151000.0; the TTM figure through Mar 2026 stood at $151000.0 (up 160.34% YoY), while the FY2026 annual figure was $151000.0, up 160.34% from the prior year.
- Current Leases for Q1 2026 stood at $151000.0, up from $146000.0 in the prior quarter.
- The five-year high for Current Leases was $282000.0 in Q3 2022, with the low at $58000.0 in Q1 2025.
- The 5-year median for Current Leases is $181000.0 (2023), against an average of $177941.2.
- The sharpest annual moves came in 2025 and 2026: Current Leases slumped 70.71% in 2025, then soared 160.34% in 2026.
- Sonoma Pharmaceuticals' Current Leases stood at $276000.0 in 2022, then sank by 34.42% to $181000.0 in 2023, then sank by 50.28% to $90000.0 in 2024, then surged by 62.22% to $146000.0 in 2025, then gained by 3.42% to $151000.0 in 2026.
- Business Quant data shows SNOA's Current Leases at $151000.0 in Q1 2026, $146000.0 in Q4 2025, and $88000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 160,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 146,000.00 |
| Sep 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 96,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Jun 30, 2024 | 155,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Jun 30, 2023 | 233,000.00 |
| Mar 31, 2023 | 256,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 250,000.00 |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | 276,000.00 |